Utilising the Memorial Sloan-Kettering Cancer Center (MSKCC) (2010) [15] and The Cancer Genome Atlas (TCGA) (provisional) prostate adenocarcinoma datasets in cBioPortal [16, 17], elevated BRF1 expression also associated with poor outcome (Figs. 1c, d and S1c, d; Tables S4 and S5). The gene discussed is BRF1; the disease is prostate adenocarcinoma.